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The information gathered by dendritic cells during the innate immune response is determinant for the type and
strength of the adaptive response. We showed that the sympathetic neurotransmitter norepinephrine inﬂuences
dendritic cell migration and T helper priming via a- and b-adrenoceptors. Others have shown that Langerhans cells
also express mRNA for b1-, b2-, and a1A- adrenoceptors and that catecholamines may inhibit the antigen-presenting
capability via b2-adrenoceptors. Here we report that oxazolone, which induces a predominant T-helper-1-type
contact hypersensitivity response, but not ﬂuorescein isothiocyanate, which induces a prevailing T-helper-2-type
response, inhibits the local norepinephrine turnover in the skin of mice during the ﬁrst 8 h of sensitization.
Oxazolone also induced higher expression of the inﬂammatory cytokines interleukin-1 and interleukin-6 mRNA in
the skin. Lack or blockade of these cytokines as well as inhibition of prostaglandin synthesis, however, did not
inﬂuence the oxazolone effect. Only the nonspeciﬁc anti-inﬂammatory steroid dexamethasone could neutralize the
effect of oxazolone. Furthermore, ﬂuorescein isothiocyanate but not oxazolone sensitization in the presence of the
speciﬁc b2-adrenoceptor antagonist ICI 118,551 enhanced the consequent contact hypersensitivity response as
well as the production of T helper 1 cytokines in draining lymph nodes; conversely T helper 2 cytokines were not
affected. Thus, the extent of T helper 1 priming in the adaptive response to a sensitizing agent seems to depend
also on its ability to modulate the local sympathetic nervous activity during the innate immune response.
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Stress events or an inadequate response to them and
anxiety have been associated with the worsening of a
variety of immune-based diseases including allergic asth-
ma, psoriasis, atopic dermatitis, and autoimmune disorders
(Bennett et al, 1993; Michel, 1994; Ligier and Sternberg,
1999; Marshall and Agarwal, 2000). A crucial immunologic
feature underlying most immunopathologies is an altered T
helper 1 (Th1)/Th2 balance (Del Prete et al, 1994). In fact,
Th1 cells promote cellular immunity, protecting against
intracellular infection and cancer, but carry the risk of organ-
specific autoimmunity. Th2 cells promote humoral immunity,
highly effective against extracellular pathogens, and are
involved in tolerance mechanisms and allergic diseases.
The initiation and type of adaptive immune responses is
controlled by innate immune recognition mediated by
dendritic cells (DC), which produce interleukin-12 (IL-12), a
prerequisite for both the activation of innate immunity and
the development of Th1 responses (Schnare et al, 2001).
In vivo IL-12 production and/or DC function may be
influenced by a variety of microenvironmental factors,
however. Recently we and others have begun to investigate
the neuronal influence on DC. DC play a crucial role in the
initiation of adaptive immune responses and in the induction
of T cell differentiation into Th effectors (Medzhitov, 2001).
Langerhans cells are DC residing within the epidermis and
often lie in apposition with epidermal nerves including both
sensory and sympathetic fibers (Torii et al, 1997; Botchkar-
ev et al, 1999). We reported that norepinephrine (NE) may
affect Langerhans cell migration (Maestroni, 2000) and
provided evidence that the extent of Th1 differentiation in
the response to an antigen might be influenced by the local
sympathetic nervous activity in the early phase of DC
stimulation (Maestroni, 2002). Another recent report shows
that Langerhans cells express mRNA for the adrenoceptors
(AR) a1A, b1, and b2. Epinephrine and NE could inhibit the
ability of Langerhans cells to present antigen for elicitation
of contact hypersensitivity (CHS) response and this effect
was inhibited by use of the b2-adrenergic antagonist ICI
118,551 (Seiffert et al, 2002). More recently we found that, in
analogy with Langerhans cells, bone marrow-derived DC
express b1-, b2-, a2A-, and a2C-AR genes. The physiologic
activation of b2-AR in DC and Langerhans cells results in
stimulation of IL-10, which in turn inhibits the chemotactic
response to the homeostatic chemokines CCL19 and
CCL21 resulting in a reduced antigen-presenting ability
(Maestroni and Mazzola, 2003).
To understand the physiologic relevance of these
findings, we investigated whether chemical allergens that
Abbreviations: AR, adrenoceptor; CHS, contact hypersen-
sitivity; DC, dendritic cells; NE, norepinephrine; Th, T helper.
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induce CHS may influence the local NE turnover and hence
its impact on Langerhans cell functions. Activation of
antigen-specific Th2 cells and B cells may, in fact, increase
NE release in the spleen and bone marrow (Kohm et al,
2000), and cytokine receptors along with receptors for other
inflammatory mediators are present on various types of
peripheral nerves, including sensory nerves (Neumann et al,
1997), sympathetic nerves, and sympathetic ganglia (Fran-
cis, 1988; Rogausch et al, 1997; Bai and Hart, 1998; Marz
et al, 1998).
We reasoned that different chemical allergens might
induce a different inflammatory response in the skin and
hence affect differently the local sympathetic tone. This, in
turn, might result in a different sympathetic influence on
Langerhans cell function and the consequent immune
response. In our experiments we used oxazolone and
fluorescein isothiocyanate (FITC) as chemical allergens in
BALB/c mice. Oxazolone is known to induce a Th1-
predominant CHS response (Webb et al, 1998; Dieli et al,
1999), whereas the response to FITC is Th2-predominant
(Tang et al, 1996; Dearman and Kimber, 2000). Here we
show that oxazolone but not FITC sensitization is asso-
ciated with an inhibition of NE turnover in the skin. This
allergen-induced modulation of the sympathetic nervous
activity during the innate phase of the immune response
depends on inflammatory mediators and contributes to the
information gathered by Langerhans cells before migration
and Th cell priming.
Results and Discussion
Effect of allergen sensitization on the rate of NE release
in the skin NE turnover analysis (Brodie et al, 1966; Kohm
et al, 2000) estimates dynamic changes in sympathetic
nerve activity that cannot be obtained by the determination
of tissue NE concentration alone. In fact, the rate of NE
release is balanced by the rate of NE synthesis, resulting in
constant tissue concentrations in spite of marked fluctua-
tions of the sympathetic activity (Brodie et al, 1966).
Therefore, to measure the specific rate of NE release in
the skin, we used a pulse-chase technique that measures
the rate of disappearance of tissue 3H-NE over time. In
addition, if experimental conditions induce a significant
change in the rate of 3H-NE release over time, the rate of NE
turnover can be calculated. To determine whether skin
sensitization with oxazolone or FITC influences the rate of
NE release from local sympathetic nerve terminals, mice
were painted on the shaved back with oxazolone or FITC at
time 0 and then injected intraperitoneally with 20 mCi of
3H-NE either immediately or after 17 h. Control mice were
painted with oxazolone or FITC vehicles alone. Skin
samples were collected at the site of antigen deposition
either at 1, 4, and 8 h or at 18, 21, and 25 h following
sensitization for NE turnover analysis. Together with skin
samples, also the local draining axillary, brachial, and
inguinal lymph nodes were collected for NE turnover
analysis. The results obtained show that oxazolone but
not FITC sensitization strongly inhibited NE turnover in the
treated skin, but only during the first 8 h after immunization
(Fig 1a, b; Table I). No effect on lymph node NE turnover
was detected at any time points (data not shown).
Oxazolone induced also a significant decrease in the total
NE content in the skin (Table I). Due to the fine balancing
between NE release and NE synthesis that keeps the tissue
catecholamine concentration constant in spite of variations
in nerve activity (Brodie et al, 1966), the NE decrease might
reflect a mechanism involving inhibition of NE synthesis.
Expression of pro-inﬂammatory cytokines in the skin
upon allergen sensitization Another transient phenomen-
on that typically occurs in the first hours after antigen
challenge is the expression of pro-inflammatory cytokines.
Different allergens may, in fact, elicit a different inflammatory
response and hence also a different expression of pro-
inflammatory cytokine genes in the skin (Holliday et al,
1997). We investigated this possibility in our model and
found that indeed oxazolone seems to induce a pro-
inflammatory cytokine profile different from that induced
by FITC. IL-1b and IL-6 mRNA levels were determined by
real-time RT-PCR. Figure 2 shows that oxazolone but not
FITC induced high expression of IL-1b at 1, 3, and 6 h after
application. At 3 and 6 h, oxazolone induced also a strong
expression of IL-6, which, in contrast, remained low after
FITC treatment. Both IL-1b and IL-6 and/or other inflam-
matory mediators were reported to inhibit peripheral
noradrenergic neurotransmission (Francis, 1988; Rogausch
et al, 1999; Xia et al, 1999). Inflammatory mediators induced
in the skin might thus mediate the observed oxazolone
effect by acting on a specific receptor expressed on nerve
terminal endings (Rogausch et al, 1997; Bai and Hart, 1998;
Marz et al, 1998).
Mechanism of the oxazolone-induced NE inhibition We
first investigated whether IL-1b and/or IL-6 were involved in
the observed phenomenon. We used IL-6 gene deficient
mice or mice pretreated with the specific IL-1 receptor
antagonist to counteract the oxazolone-induced inhibition
of NE turnover. No effect was observed either in IL-6 gene
knockout mice or in the IL-1 receptor antagonist treated
mice (data not shown). In other experiments we also used
TNF-a gene knockout mice or mice pretreated with the
cycloxygenase inhibitor indomethacin with equally negative
results. Hence we could conclude that IL-1b, IL-6, TNF-a,
and prostaglandins were not involved in the oxazolone-
mediated inhibition of the local NE turnover. The increased
IL-1b and IL-6 mRNA expression might thus be the effect
rather than the cause of the reduced NE turnover in the skin.
NE has been widely reported, in fact, to exert anti-
inflammatory effects including inhibition of IL-1b and IL-6
production (Elenkov and Chrousos, 2002; Maestroni, 2002;
Seiffert et al, 2002; Maestroni and Mazzola, 2003).
To challenge the hypothesis that other inflammatory
mediators were indeed involved in the oxazolone effect, the
potent and nonspecific anti-inflammatory steroid dexa-
methasone was taken into consideration. We pretreated
groups of mice with dexamethasone (10 mg per kg body
weight, subcutaneously) before sensitization with oxazolone
or vehicle and then we assessed the local NE turnover.
Figure 3 shows that dexamethasone pretreatment abol-
ished completely the effect of oxazolone on NE turnover. In
fact, the slope of the specific activity regression lines and
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the NE turnover rate (inset) were similar in both oxazolone-
and vehicle-treated mice, suggesting that dexamethasone-
sensitive factors are indeed the mediators of the oxazolone
effect on NE turnover. Further studies are clearly needed to
identify these factors among the multiple pathways affected
by dexamethasone.
Effect of the b2-AR antagonist ICI 118,551 on CHS
response and cytokine production As Langerhans cell
and DC antigen-presenting properties have been shown to
be modulated by catecholamines, the apparent ability of
oxazolone to inhibit the local norepinephrine turnover during
the innate response might be relevant in determining the
adaptive response. We investigated this possibility, using
repeated exposure of mice to either oxazolone or FITC in
the presence or absence of the selective b2-AR antagonist
ICI 118,551. Repeated exposure to allergens is needed to
elicit a divergent cytokine secretion pattern (Dearman et al,
1997). Six days later the CHS response as well as the
amount of Th1 and Th2 cytokines released by lymph node
cells were measured. Table II shows the influence of ICI
118,551 treatment during sensitization with FITC or oxazo-
lone on Th cytokine secretion pattern and the CHS
response. The major difference upon repeated exposure
to the allergens concerns IL-5 and, especially, IL-4, which
were significantly higher in lymph node cells from FITC-
sensitized mice confirming the Th2 priming properties of
FITC. Interestingly no other cytokine, including IFN-g,
showed any significant difference between FITC- and
oxazolone-sensitized mice. The presence of ICI 118,551
during FITC but not oxazolone sensitization, however,
induced a significant increase of IFN-g and IL-2 production
as well as of the CHS response. The CHS response was
also higher upon oxazolone sensitization in comparison to
FITC sensitization. The presence of ICI 118,551 during FITC
sensitization abolished this difference.
Figure 1
Effect of allergen sensitization on the rate of
NE release in the skin. Either 1, 4, or 8 h (a)
and 18, 21, or 25 h (b) after application of
oxazolone (OX), FITC, or vehicle (VEH), skin
samples from 3H-NE-treated mice were col-
lected for determination of the rate of NE
release as NE turnover rate (ng per g per h;
inset). Each point represents the mean  SD
for specific activity from 21 mice per experi-
ment; r values are the least squares regression
coefficients using raw data points for each line.
The p values are indicated when significant.
See Table I for tissue levels.
Table I. The effect of oxazolone or FITC painting on the rate of NE release in the skin 1–8 h after allergen administration
Group n Tissue NE (ng per g) p Slope p
OXA 21 39.1  8.3 o0.01 0.008 o0.002
OXA vehicle 42 53.8  14.7 0.087
FITC 21 60.9  12.7 0.061 n.s.
FITC vehicle 21 52.3  9.1 0.057
OXAþdexamethasone 21 54.1  9.6 n.s. 0.069 n.s.
The experimental design is described in the legend to Fig 1. The NE values are the mean  the standard deviation. Slope is relative at the line
representing the log cpm of 3H-NE per ng of tissue NE.
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These results suggest that the physiologic presence of
NE released by sympathetic nerve terminals in the skin
influences the response to FITC but not to oxazolone. It
seems reasonable to conclude that this depends on the
ability of oxazolone to inhibit the local NE turnover, probably
by its ability to induce inflammatory mediators in the skin.
We have shown that NE may act on b2-AR expressed in
epidermal Langerhans cells, decreasing their migration
capability possibly by stimulating IL-10 production, which
in turn inhibited the chemotactic response to the homeo-
static chemokines CCL19 and CCL21. These events led to
reduced Th1 priming and CHS response (Maestroni and
Mazzola, 2003) confirming a previous report (Seiffert et al,
2002). Hence, the ability of ICI 118,551 to increase Th1
priming and the CHS response to FITC, as well as its
inefficacy in oxazolone-treated mice, reveals the existence
of a physiologic sympathetic modulation of Langerhans cell
function. It should also be noted that ICI 118,551 did not
apparently affect Th2 cytokines but only increased Th1
priming. The physiologic function of NE might therefore be
that of limiting Th1 priming but not of inducing a Th2 shift.
This effect contributes in determining the cytokine profile in
the response to certain allergens, however. In general,
contact sensitizers induce a Th1 response whereas Th2
responses are observed after exposure to respiratory
allergens. Thus, the inflammatory response to contact
sensitizers seems to include a blockade of the local NE
turnover. This, together with the antigenic challenge,
enhances the antigen-presenting ability of Langerhans cells,
increasing Th1 priming and the consequent CHS response.
Figure 2
Cytokine mRNA expression in the skin of mice after sensitization
with oxazolone or FITC as determined by real-time RT-PCR. One
representative experiment of three is shown.
Figure3
Effect of dexamethasone on the oxazolone-induced inhibition of
NE turnover. The mice were injected subcutaneously with dexametha-
sone (D, 10 mg per kg body weight) just before sensitization with
oxazolone (OX) and injection of 3H-NE for NE turnover analysis. Other
groups of mice were painted with vehicle (VEH) alone and injected with
3H-NE as control. Each point represents the mean  SD for specific
activity from 21 mice per experiment; r values are the least squares
regression coefficients using raw data points for each line. See Table I
for tissue levels.
Table II. The effect of ICI 118,551 administered during sensitization on Th cytokine secretion pattern and CHS response to FITC
and oxazolone
TNF-a (pg per mL) IFN-c (pg per mL) IL-5 (pg per mL) IL-4 (pg per mL) IL-2 (pg per mL) CHS (lm)
FITC 335  66 8701  3484 360  117b 97  36b 81  42 122  38
FITCþ ICI 386  126 19993  5873a 403  186b 118  56b 152  38a 183  27a
OX 367  65 15609  2199a 215  92 23  9 102  37 197  30
OXþ ICI 382  86 14909  1974a 196  87 18  6 97  35 218  46
Mice were sensitized to FITC or oxazolone (OX) by repeated exposure in the presence or absence of the selective b2-AR antagonist ICI 118,551. Six
days later the Th cytokine secretion pattern in lymph node cells and the CHS response were assessed. The figures represent the mean  SD of three
experiments (12 mice per group).
apo0.01 vs FITC.
bpo0.02 vs OX, OXþ ICI.
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In the presence of a lower or different inflammatory
response such as that elicited by respiratory allergens, NE
is not inhibited and it may act on b2-AR in Langerhans cells
limiting their Th1 priming ability. Of course, NE might act
also on skin components other than Langerhans cells,
although our previous findings point to Langerhans cells
and DC as main effectors of the immune-modulating
properties of NE, at least during the innate immune
response (Maestroni, 2000, 2002; Maestroni and Mazzola,
2003).
The early, innate response to allergens (antigens) seems
thus to involve the local sympathetic nervous system, which
may impact on DC priming properties. Our findings reveal a
basic physiologic mechanism that contributes to the
information gathered by DC in the early phase of their
activation. Future studies should be aimed at detailing the
mechanisms and the physiopathologic implications of this
surprising neuro-immunologic connection.
Materials and Methods
The experiments have been approved by our institute and by the local
veterinary authority.
Mice BALB/c inbred mice were purchased from Harlan, Italy. All
the mice used in the experiments were female, 2–4 mo old, and
were maintained in our animal room under a standard 12 h
photoperiod, at 21  11C, with food and water ad libitum.
Drugs and reagents NE, dexamethasone, oxazolone, and FITC
were purchased from Sigma, St Louis, MO. The selective b2-AR
antagonist ICI 118,551 was purchased from Tocris Cookson, UK.
3H-NE was purchased from NEN Life Sciences, Switzerland.
NE turnover analysis The analysis was performed according to a
recently published method with some modifications (Kohm et al,
2000). Mice were painted on the shaved back with 150 mL of 3%
oxazolone dissolved in a 4:1 (vol/vol) acetone:olive oil mixture or
with 150 mL of 1% FITC in 1:1 acetone:dibutylphthalate. Control
mice were painted with the respective vehicles. In addition, all mice
were injected intraperitoneally with 20 mCi of 3H-NE in 200 mL of
saline plus 0.1% ascorbic acid either at the time of or 17 h
following allergen administration. Skin and the draining lymph
nodes were collected from the mice 1, 4, or 8 h after 3H-NE
injection and stored at 801C until time of analysis. At each
sampling time the mice were sacrificed and a piece of skin never
exceeding 3 cm2 in size was excised from the mid back on the right
side, i.e., from the central part of the painted area. The weight of
the skin samples ranged from 70 to 120 mg. Skin samples and
lymph nodes were homogenized in cold phosphate saline (pH 7.4)
using a Polytron tissue homogenizer (Kinematica, Switzerland) and
centrifuged. The supernatant was mixed with activated alumina for
30 min at room temperature. The alumina was then washed with
water and the alumina-bound NE was eluted with 400 mL 0.4 M
perchloric acid. The concentration of NE in the eluate was
measured following high performance liquid chromatography
separation and electrochemical detection. The recovery of NE
from alumina was approximately 70%. Aliquots (175 mL) of alumina
eluates were mixed with 5 mL of scintillation cocktail. The specific
activity of the 3H-NE (cpm per ng of NE) was calculated as the
quotient of 3H-NE present in the tissue and the total tissue NE
content. To determine NE turnover rates (rate constant  tissue
NE) the specific activity of tissue NE was plotted as a function of
time. The decay of specific activity is a first-order function, a
straight line with a negative slope, and decay lines were calculated
by the method of least squares. The rate constant represents the
fraction of the NE pool replaced per unit time (h–1). Rate constants
(k) were calculated from the slope of the logarithm of the specific
activity versus time relationship (0.434k¼ slope). Differences
between the slopes of the regression lines were tested by Student’s
t test, using the pooled standard errors of sample regression.
Real-time RT-PCR To reveal the expression of pro-inflammatory
cytokine gene expression in the skin, mice were painted with
oxazolone or FITC as described above and skin samples were
taken after 1, 3, and 6 h. Control mice were painted with the
vehicles alone. Skin samples were immediately frozen in liquid
nitrogen and pulverized in a cold porcelain mortar. Total RNA
isolated from the skin was reverse transcribed using random
examers and the TaqMan Reverse Transcription kit (Perkin-Elmer
Applied Biosytems, Foster City, CA). A relative quantification of IL-
1b and IL-6 and was done on an ABI PRISM 7700 Sequence
Detector (Perkin Elmer) using predeveloped TaqMan reagents
according to manufacturer’s instructions. Amplification of 18S
rRNA was done for each sample as endogenous control of the
amount and quality of total RNA added to each reaction. Thermal
cycling conditions were 2 min at 501C and 10 min at 951C, followed
by 40 cycles of two-step PCR consisting of 15 s at 951C and 1 min
at 601C. All samples were amplified in duplicate. The threshold
cycle Ct, which correlates inversely with the target mRNA levels,
was measured as the cycle number at which the reported
fluorescence emission increased above a threshold level. For each
sample, the amount of target mRNA (IL-1b, IL-6) was expressed as
an n-fold difference relative to the amount of target mRNA in
control, vehicle-painted skin. The formula used to determine this
value is 2–DDCt, where DCt is determined by subtracting the average
18S rRNA value from the average target DCt value. The calculation
of DDCt involves the subtraction of the DCt of vehicle skin from the
target DCt value.
Assay for CHS to FITC Mice were sensitized on the shaved back
with FITC or oxazolone in the presence or absence of ICI 118,551
(100 mM). This treatment was repeated three times, every other day
during 6 d. Six days after the last treatment, the mice were
challenged by applying 20 mL of 0.5% FITC or 1% oxazolone on
the dorsal and ventral sides of the right ear. As a control the left ear
was painted with an identical amount of vehicle (acetone:dibu-
tylphthalate, 1:1). The CHS response was determined by measur-
ing the degree of ear swelling of the FITC-painted ear compared
with that of the vehicle-treated contralateral ear at 24 h after
challenge using a digital micrometer (Mitutoyo, Japan). The results
were expressed as net ear swelling, which was calculated by
subtracting the thickness of the vehicle-treated ear from the
thickness of the FITC-challenged ear.
Cytokines in lymph node cells Mice were sensitized on the
shaved back with FITC or oxazolone in the presence or absence of
ICI 118,551 (100 mM). This treatment was repeated three times,
every other day during 6 d. Skin-draining, axillary, and inguinal
lymph nodes were collected 6 d after the last sensitization
treatment and single-cell suspensions were prepared. The cells
were then stimulated with plate-bound anti-CD3 antibodies.
Ninety-six-well U-bottom plates were precoated with hamster
antimouse CD3 (25 mg per mL, Pharmingen, Allschwil, Switzerland)
or hamster IgG isotype control for 90 min at 371C. Cells were
seeded at 5  105 cells per 200 mL per well, and incubated in RPMI
1640, 10% fetal bovine serum at 371C for 48 h. Next, culture
supernatants were collected and the concentration of interferon-g
(IFN-g), IL-4, IL-5, tumor necrosis factor a (TNF-a), and IL-2 were
quantitated by flow cytometry (FACScalibur, Becton Dickinson,
Allschwil, Switzerland) using a Cytometric Bead Array kit (BD
Pharmingen). Before collecting the lymph nodes, the CHS
response was assessed as reported.
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